The Mouth Cancer Charter
The Mouth Cancer Charter has been created by the Oral Health Foundation as part of November’s Mouth Cancer Action Month. It addresses the alarming rise in mouth cancer cases in the UK, with over 10,825 diagnoses each year – a 133% increase over two decades.
With survival rates remaining low at just 50% after five years, largely due to a lack of public awareness, the Mouth Cancer Charter outlines seven key measures to combat the issue.
Key Measures outlined
These include a government funded campaign to;
- improve knowledge of the signs, symptoms, and risk factors,
- enhanced access to routine dental care,
- better training for healthcare professionals,
- streamlined referral pathways,
- and investment in advanced diagnostic technologies.

Free dental check ups ensure fair access to care
The Charter also advocates for free dental check-ups and treatment for mouth cancer patients, removing financial barriers and ensuring fair access to care.
By implementing these measures, the Charter, signed by Oracle Head & Neck Cancer UK, aims to save lives, improve patient outcomes, and reduce the burden of mouth cancer across the UK.
Please get involved
We need your help! Join our RACE against time by donating, fundraising, or spreading awareness. Every action makes a difference.⏳ Every day counts when it comes to cancer – let’s make sure no one has to wait.💬 Join us in demanding better care!
See also patient stories to hear about other people diagnosed with Head and Neck Cancers including mouth cancer.
Have you got a symptom, are you being diagnosed, going through treatment, or a friend/carer of someone who is? Please join our private Facebook Group to get support and advice from fellow patients and carers.
Julian Gilbert joins Oracle Head & Neck Cancer UK as a trustee
Julian Gilbert, founder of Wealth Matters and a long-standing fundraiser who has had head and Neck Cancer, has joined our board of trustees.
Eating well after head and neck cancer treatment: join our November webinar
A specialist dietitian and a patient talk about food, swallowing and eating out after head and neck cancer treatment.
Thank you to our brilliant Great North Run runners!
This September, two incredible supporters took to the streets of Newcastle for the Great North Run, the world’s largest half marathon, and we couldn’t be prouder of them both. Beth Robinson Scales completed the 13.1-mile route in searing heat, raising over £3,800 for Oracle. Beth ran in honour of her husband Steve, following his recurrence, and…
Bringing the UK’s head and neck oncology community together
The Oracle Head & Neck Cancer UK Oncology Meeting 2026 takes place tomorrow, Friday 25th September, at The Milner Hotel, York. Now in its third year under the Oracle umbrella, this free educational meeting brings together head and neck oncology specialists from around 40 centres across the UK, spanning radiography, nursing, clinical and medical oncology,…
October Webinar: Immunotherapy & Other Developing Treatments
Professor Kevin Harrington explores the latest immunotherapy treatments for head and neck cancer in our upcoming webinar on 6 October.
Mark Hodgson walks 310km in August for Oracle Head and Neck Cancer UK
A Leeds private investigator who was treated for stage 4 cancer of the throat and tongue is walking 10 kilometres every day throughout August for Oracle Head & Neck Cancer UK. He has already passed his original £10,000 target, with 11 days of the challenge still to run. Mark Hodgson is a director of Tremark Associates, a Leeds…
September Webinar: Understanding Head & Neck cancer late effects in survivorship.
From cure to consequence:
Understanding Head & Neck cancer late effects in survivorship.
Thursday 10 September 2026
18:00 – 19:00 pm
Our Late Effects webinar will feature Sabina Khan and Emma Hallam, Macmillan Consultant Radiographers. Both specialise in head and neck post-treatment late effects. They’ll be joined by patient Karen Liesching-Schroder, who will share the patient perspective drawing on her experience of diagnosis, treatment and late effects.